# A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

> **NCT04006808** · PHASE1,PHASE2 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 184 (estimated)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** PED-HZ/su

## Key facts

- **NCT ID:** NCT04006808
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-10-25
- **Primary completion:** 2026-05-01
- **Final completion:** 2027-03-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04006808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04006808, "A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04006808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*